| Year |
Citation |
Score |
| 2023 |
Khan M, Hearn K, Parry C, Rasid M, Brim H, Ashktorab H, Kwabi-Addo B. Mechanism of Antitumor Effects of Saffron in Human Prostate Cancer Cells. Nutrients. 16. PMID 38201944 DOI: 10.3390/nu16010114 |
0.714 |
|
| 2023 |
Creighton CJ, Zhang F, Zhang Y, Castro P, Hu R, Islam M, Ghosh S, Ittmann M, Kwabi-Addo B. Comparative and integrative analysis of transcriptomic and epigenomic-wide DNA methylation changes in African American prostate cancer. Epigenetics. 18: 2180585. PMID 37279148 DOI: 10.1080/15592294.2023.2180585 |
0.595 |
|
| 2021 |
Tailor K, Paul J, Ghosh S, Kumari N, Kwabi-Addo B. RASAL2 suppresses the proliferative and invasive ability of PC3 prostate cancer cells. Oncotarget. 12: 2489-2499. PMID 34966481 DOI: 10.18632/oncotarget.28158 |
0.564 |
|
| 2021 |
Keith SW, Kwabi-Addo B, Zeigler-Johnson C. Interactions Between Obesity and One-Carbon Metabolism Genes in Predicting Prostate Cancer Outcomes Among White and Black Patients. Journal of Racial and Ethnic Health Disparities. PMID 33432479 DOI: 10.1007/s40615-020-00958-6 |
0.459 |
|
| 2020 |
Wang S, Tailor K, Kwabi-Addo B. Androgen-induced Epigenetic Profiles of Polycomb and Trithorax Genes in Prostate Cancer Cells. Anticancer Research. 40: 2559-2565. PMID 32366400 DOI: 10.21873/Anticanres.14226 |
0.741 |
|
| 2019 |
Apprey V, Wang S, Tang W, Kittles RA, Southerland WM, Ittmann M, Kwabi-Addo B. Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity. Anticancer Research. 39: 5861-5866. PMID 31704810 DOI: 10.21873/Anticanres.13790 |
0.628 |
|
| 2018 |
Moses-Fynn E, Tang W, Beyene D, Apprey V, Copeland R, Kanaan Y, Kwabi-Addo B. Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men. Plos One. 13: e0203322. PMID 30204798 DOI: 10.1371/Journal.Pone.0203322 |
0.516 |
|
| 2018 |
Kwabi-Addo B, Moses-Fynn E, Tang W, Beyene D, Apprey V, Kanaan Y. Abstract 3327: Correlating blood-based DNA methylation markers and prostate cancer risk factors in African-American men Cancer Research. 78: 3327-3327. DOI: 10.1158/1538-7445.Am2018-3327 |
0.695 |
|
| 2016 |
Wang S, Clarke PA, Davis R, Mumuni S, Kwabi-Addo B. Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer. Cytokine. 86: 110-118. PMID 27500645 DOI: 10.1016/J.Cyto.2016.07.006 |
0.727 |
|
| 2015 |
Akinboye ES, Bamji ZD, Kwabi-Addo B, Ejeh D, Copeland RL, Denmeade SR, Bakare O. Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines. Bioorganic & Medicinal Chemistry. 23: 5839-45. PMID 26187015 DOI: 10.1016/J.Bmc.2015.06.072 |
0.518 |
|
| 2015 |
Devaney JM, Wang S, Furbert-Harris P, Apprey V, Ittmann M, Wang BD, Olender J, Lee NH, Kwabi-Addo B. Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. Epigenetics : Official Journal of the Dna Methylation Society. 10: 319-28. PMID 25864488 DOI: 10.1080/15592294.2015.1022019 |
0.657 |
|
| 2014 |
Wing MR, Devaney JM, Joffe MM, Xie D, Feldman HI, Dominic EA, Guzman NJ, Ramezani A, Susztak K, Herman JG, Cope L, Harmon B, Kwabi-Addo B, Gordish-Dressman H, Go AS, et al. DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 29: 864-72. PMID 24516231 DOI: 10.1093/Ndt/Gft537 |
0.302 |
|
| 2014 |
Kwabi-Addo B, Wang S, Devaney J. Abstract 388: Epigenome-wide profiling identified significant differences in DNA methylation between African-American and European-American men with prostate cancer Cancer Research. 74: 388-388. DOI: 10.1158/1538-7445.Am2014-388 |
0.706 |
|
| 2013 |
Devaney JM, Wang S, Funda S, Long J, Taghipour DJ, Tbaishat R, Furbert-Harris P, Ittmann M, Kwabi-Addo B. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia Prostate Cancer and Prostatic Diseases. 16: 292-300. PMID 23896626 DOI: 10.1038/Pcan.2013.21 |
0.69 |
|
| 2013 |
Tbaishat R, Wang S, Kwabi-Addo B. Abstract 1985: ZNF783, a novel zinc finger protein has tumor suppressor function in prostate cancer. Cancer Research. 73: 1985-1985. DOI: 10.1158/1538-7445.Am2013-1985 |
0.528 |
|
| 2013 |
Kwabi-Addo B, Wang S, Furbert-Harris P, Yegnasubramanian S, Devaney J. Abstract 1974: Functional characterization of Basonuclin 1 (BNC1): a novel tumor suppressor gene commonly downregulated in human prostate cancer. Cancer Research. 73: 1974-1974. DOI: 10.1158/1538-7445.Am2013-1974 |
0.789 |
|
| 2012 |
Akinboye ES, Rosen MD, Denmeade SR, Kwabi-Addo B, Bakare O. Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer. Journal of Medicinal Chemistry. 55: 7450-9. PMID 22867001 DOI: 10.1021/Jm300426Q |
0.452 |
|
| 2012 |
Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B. Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer. Plos One. 7: e37928. PMID 22701537 DOI: 10.1371/Journal.Pone.0037928 |
0.456 |
|
| 2012 |
Kwabi-Addo B, Wang S, Lee NH, Ittmann M, Suer F, Devaney J. Abstract 4999: Genome-wide methylation array of human prostate tissues using illumina infunium 450K bead chip reveals distinct DNA methylation signatures with potential as clinical predictors Cancer Research. 72: 4999-4999. DOI: 10.1158/1538-7445.Am2012-4999 |
0.69 |
|
| 2011 |
Darimipourain M, Wang S, Ittmann M, Kwabi-Addo B. Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer Prostate Cancer and Prostatic Diseases. 14: 279-285. PMID 21826097 DOI: 10.1038/Pcan.2011.33 |
0.584 |
|
| 2011 |
Daremipouran M, Wang SP, Ellis A, Bamji Z, Kwabi-Addo B. Abstract 3033: NKX2-5, a potential tumor suppressor gene in prostate cancer Cancer Research. 71: 3033-3033. DOI: 10.1158/1538-7445.Am2011-3033 |
0.787 |
|
| 2011 |
Devaney JM, Suer F, Kwabi-Addo B. Abstract ED03-03: Tools for analysis of genome-wide methylation data: An application to prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-Ed03-03 |
0.634 |
|
| 2011 |
Kwabi-Addo B. Abstract ED03-01: Validation and quantitation of DNA methylation changes Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-Ed03-01 |
0.726 |
|
| 2010 |
Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3539-47. PMID 20606036 DOI: 10.1158/1078-0432.Ccr-09-3342 |
0.668 |
|
| 2010 |
Kwabi-Addo B, Wang S, Lee NH, Estecio MR, Jelinek J, Chung W, Ittmann MM. Abstract 167: Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men Cancer Research. 70: 167-167. DOI: 10.1158/1538-7445.Am10-167 |
0.763 |
|
| 2010 |
Kwabi-Addo B, Wang S, Yegnasubramanian S. Abstract B62: Epigenetic DNA methylation changes may underlie racial differences and susceptibility to prostate cancer. Cancer Epidemiology, Biomarkers & Prevention. 19. DOI: 10.1158/1055-9965.Disp-10-B62 |
0.726 |
|
| 2009 |
Kwabi-Addo B, Ren C, Ittmann M. DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics. 4: 54-61. PMID 19164898 DOI: 10.4161/Epi.4.1.7400 |
0.711 |
|
| 2008 |
Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nature Genetics. 40: 741-50. PMID 18488029 DOI: 10.1038/Ng.159 |
0.617 |
|
| 2008 |
Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, Issa JP. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. Plos One. 3: e2079. PMID 18446232 DOI: 10.1371/Journal.Pone.0002079 |
0.709 |
|
| 2007 |
Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP. Age-related DNA methylation changes in normal human prostate tissues. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3796-802. PMID 17606710 DOI: 10.1158/1078-0432.Ccr-07-0085 |
0.682 |
|
| 2007 |
Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Relaxin promotes prostate cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 1695-702. PMID 17363522 DOI: 10.1158/1078-0432.Ccr-06-2492 |
0.697 |
|
| 2006 |
Wang J, Thompson B, Ren C, Ittmann M, Kwabi-Addo B. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. The Prostate. 66: 613-24. PMID 16388505 DOI: 10.1002/Pros.20353 |
0.752 |
|
| 2005 |
Rosa AL, Wu YQ, Kwabi-Addo B, Coveler KJ, Sutton VR, Shaffer LG. Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32 Chromosome Research. 13: 809-818. PMID 16331412 DOI: 10.1007/S10577-005-1015-4 |
0.333 |
|
| 2004 |
Kwabi-Addo B, Ozen M, Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer Endocrine-Related Cancer. 11: 709-724. PMID 15613447 DOI: 10.1677/Erc.1.00535 |
0.644 |
|
| 2004 |
Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Research. 64: 4728-35. PMID 15256439 DOI: 10.1158/0008-5472.Can-03-3759 |
0.72 |
|
| 2004 |
Polnaszek N, Kwabi-Addo B, Wang J, Ittmann M. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia. The Prostate. 60: 18-24. PMID 15129425 DOI: 10.1002/Pros.20026 |
0.611 |
|
| 2003 |
Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M. Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Research. 63: 5754-60. PMID 14522896 |
0.538 |
|
| 2003 |
Lu S, Chen GL, Ren C, Kwabi-Addo B, Epner DE. Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. Biochemical Pharmacology. 66: 791-800. PMID 12948860 DOI: 10.1016/S0006-2952(03)00406-4 |
0.608 |
|
| 2001 |
Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression Proceedings of the National Academy of Sciences of the United States of America. 98: 11563-11568. PMID 11553783 DOI: 10.1073/Pnas.201167798 |
0.729 |
|
| 2001 |
Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M. Alternative splicing of fibroblast growth factor receptor 2 mrna in prostate cancer The Prostate. 46: 163-172. PMID 11170144 DOI: 10.1002/1097-0045(20010201)46:2<163::Aid-Pros1020>3.0.Co;2-T |
0.689 |
|
| 2000 |
Ropiquet F, Giri D, Kwabi-Addo B, Schmidt K, Ittmann M. FGF-10 is expressed at low levels in the human prostate. The Prostate. 44: 334-338. PMID 10951499 DOI: 10.1002/1097-0045(20000901)44:4<334::Aid-Pros11>3.0.Co;2-G |
0.596 |
|
| 2000 |
Kwabi-Addo B, Thompson TC, Ittmann M. Absence of PTEN/MMAC1 pseudogene in mice. Dna and Cell Biology. 19: 301-305. PMID 10855797 DOI: 10.1089/10445490050021212 |
0.376 |
|
| Show low-probability matches. |